FMP
Sep 15, 2025 10:00 PM - Stuart Mooney(Last modified: Sep 16, 2025 1:28 PM)
Image credit: Google Images
Dave & Buster's Entertainment, Inc. (NASDAQ: PLAY) is a well-known operator of entertainment and dining venues. The company offers a unique combination of food, drinks, and arcade games, attracting a diverse customer base. In the competitive landscape, Dave & Buster's faces rivals like Main Event Entertainment and Chuck E. Cheese, which also provide similar entertainment experiences.
On September 15, 2025, PLAY reported earnings per share (EPS) of $0.32, missing the estimated $0.88. This represents a significant decline from the previous year's EPS of $0.99 for the same period. Analysts had anticipated a 21.4% decrease in EPS, but the actual results were even lower, highlighting challenges the company faces in maintaining profitability.
The company's revenue for the quarter was approximately $557.4 million, slightly below the estimated $562.7 million. Despite a modest year-over-year increase of 0.9% from $557.1 million, the revenue fell short of expectations. This shortfall may have contributed to the downward revision of the consensus EPS estimate by 4.6% over the past month, as highlighted by analysts.
Dave & Buster's recently appointed Tarun Lal as the new CEO on July 15, 2025. The stock experienced a slight decline of 0.4%, closing at $22.23 on the Wednesday following the earnings report. Truist Securities analyst Jake Bartlett maintained a Hold rating on the stock, adjusting the price target from $29 to $27, reflecting cautious sentiment among analysts.
The company's financial metrics reveal a price-to-earnings (P/E) ratio of 21.76 and a price-to-sales ratio of 0.40. The enterprise value to sales ratio is 1.91, while the enterprise value to operating cash flow ratio is 13.49. With a debt-to-equity ratio of 21.88 and a current ratio of 0.26, Dave & Buster's financial leverage and liquidity position are areas of concern for investors.
JFrog Ltd. (NASDAQ:FROG) is a technology company known for its innovative software solutions, particularly in the DevOps...
aTyr Pharma, Inc. (NASDAQ:ATYR) is a biotechnology company focused on developing innovative medicines for patients with ...